Commentary: Folly of FDA-approval studies for bone morphogenetic protein

COMMENTARY ON: Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011;11:471–91 (in this issue).